Sexualität bei Jugendlichen mit rheumatischen Erkrankungen

Standard

Sexualität bei Jugendlichen mit rheumatischen Erkrankungen : Verhütung, HPV-Impfung und Schwangerschaft. / Fischer-Betz, Rebecca; Haase, Isabell; Oommen, Prasad Thomas.

In: Z RHEUMATOL, Vol. 77, No. 8, 10.2018, p. 667-676.

Research output: SCORING: Contribution to journalSCORING: Review articleResearch

Harvard

APA

Vancouver

Bibtex

@article{2c897f25eec3475985d44d898bd98a73,
title = "Sexualit{\"a}t bei Jugendlichen mit rheumatischen Erkrankungen: Verh{\"u}tung, HPV-Impfung und Schwangerschaft",
abstract = "Young patients and adolescents with chronic rheumatic diseases have the same desires, fears and needs in terms of sexuality and pregnancy as their healthy peers. In most cases adolescents are already sexually active before transition from pediatric to adult rheumatological care takes place. Pregnancies in women with rheumatic diseases are associated with increased maternal and fetal risks, especially when they occur unplanned in the course of active disease or under teratogenic drugs. Safe contraception is therefore crucial in preventing unwanted pregnancies. The choice of contraception should anticipate the safety of the method of contraception as well as age-dependent practicability. A strategy of {"}double protection{"} through the use of condoms for contraception and prevention of sexually transmitted diseases combined with another safe contraception method should be recommended. Women with rheumatic diseases are more susceptible to acquire persisting human papilloma virus (HPV) infections and the subsequent progression to cervical cancer. In women with rheumatic diseases HPV vaccination induces high seroconversion rates, is safe and does not seem to induce disease activity. The care of adolescent women with rheumatic diseases before, during and after medical transition needs to encompass an open, early and continuous counselling regarding these topics in order to retain the individual health-related quality of life and to adapt this care to age-specific needs.",
keywords = "Adolescent, Contraception, Female, Humans, Papillomavirus Infections/prevention & control, Pregnancy, Quality of Life, Rheumatic Diseases/complications, Sexuality, Vaccination",
author = "Rebecca Fischer-Betz and Isabell Haase and Oommen, {Prasad Thomas}",
year = "2018",
month = oct,
doi = "10.1007/s00393-018-0522-6",
language = "Deutsch",
volume = "77",
pages = "667--676",
journal = "Z RHEUMATOL",
issn = "0340-1855",
publisher = "D. Steinkopff-Verlag",
number = "8",

}

RIS

TY - JOUR

T1 - Sexualität bei Jugendlichen mit rheumatischen Erkrankungen

T2 - Verhütung, HPV-Impfung und Schwangerschaft

AU - Fischer-Betz, Rebecca

AU - Haase, Isabell

AU - Oommen, Prasad Thomas

PY - 2018/10

Y1 - 2018/10

N2 - Young patients and adolescents with chronic rheumatic diseases have the same desires, fears and needs in terms of sexuality and pregnancy as their healthy peers. In most cases adolescents are already sexually active before transition from pediatric to adult rheumatological care takes place. Pregnancies in women with rheumatic diseases are associated with increased maternal and fetal risks, especially when they occur unplanned in the course of active disease or under teratogenic drugs. Safe contraception is therefore crucial in preventing unwanted pregnancies. The choice of contraception should anticipate the safety of the method of contraception as well as age-dependent practicability. A strategy of "double protection" through the use of condoms for contraception and prevention of sexually transmitted diseases combined with another safe contraception method should be recommended. Women with rheumatic diseases are more susceptible to acquire persisting human papilloma virus (HPV) infections and the subsequent progression to cervical cancer. In women with rheumatic diseases HPV vaccination induces high seroconversion rates, is safe and does not seem to induce disease activity. The care of adolescent women with rheumatic diseases before, during and after medical transition needs to encompass an open, early and continuous counselling regarding these topics in order to retain the individual health-related quality of life and to adapt this care to age-specific needs.

AB - Young patients and adolescents with chronic rheumatic diseases have the same desires, fears and needs in terms of sexuality and pregnancy as their healthy peers. In most cases adolescents are already sexually active before transition from pediatric to adult rheumatological care takes place. Pregnancies in women with rheumatic diseases are associated with increased maternal and fetal risks, especially when they occur unplanned in the course of active disease or under teratogenic drugs. Safe contraception is therefore crucial in preventing unwanted pregnancies. The choice of contraception should anticipate the safety of the method of contraception as well as age-dependent practicability. A strategy of "double protection" through the use of condoms for contraception and prevention of sexually transmitted diseases combined with another safe contraception method should be recommended. Women with rheumatic diseases are more susceptible to acquire persisting human papilloma virus (HPV) infections and the subsequent progression to cervical cancer. In women with rheumatic diseases HPV vaccination induces high seroconversion rates, is safe and does not seem to induce disease activity. The care of adolescent women with rheumatic diseases before, during and after medical transition needs to encompass an open, early and continuous counselling regarding these topics in order to retain the individual health-related quality of life and to adapt this care to age-specific needs.

KW - Adolescent

KW - Contraception

KW - Female

KW - Humans

KW - Papillomavirus Infections/prevention & control

KW - Pregnancy

KW - Quality of Life

KW - Rheumatic Diseases/complications

KW - Sexuality

KW - Vaccination

U2 - 10.1007/s00393-018-0522-6

DO - 10.1007/s00393-018-0522-6

M3 - SCORING: Review

C2 - 30135988

VL - 77

SP - 667

EP - 676

JO - Z RHEUMATOL

JF - Z RHEUMATOL

SN - 0340-1855

IS - 8

ER -